Cyprus vs North Macedonia: Share of S. aureus infections resistant to methicillin
Cyprus
55.9%
in 2022
North Macedonia
53.9%
in 2022
Cyprus rank
5th
North Macedonia rank
8th
Share of S. aureus infections resistant to methicillin over time
- Cyprus
- North Macedonia
How they compare
Cyprus currently reports 55.9% against 53.9% in North Macedonia, a difference of 2.0%.
The two have swapped places 3 times across 6 shared years of data; in 2017 it was North Macedonia ahead.
Cyprus ranks 5th and North Macedonia ranks 8th of 45 countries.
Across the 2 decades both report, Cyprus averaged higher in 1 and North Macedonia in 1.
Head to head by decade
| Decade | Cyprus | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 57.1% | 51.0% | 6.2% | Cyprus |
| 2020s | 49.5% | 78.2% | 28.7% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Cyprus or North Macedonia?
- Cyprus, at 55.9% against 53.9% in North Macedonia as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Cyprus and North Macedonia?
- 2.0%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and North Macedonia?
- 6 years are reported by both, from 2017 to 2022.
- How do Cyprus and North Macedonia rank globally for share of s. aureus infections resistant to methicillin?
- Cyprus ranks 5th and North Macedonia ranks 8th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).